CTI Life Sciences Fund L.P.
Venture capitalMontréal · Seed–Late Stage · 9 people tracked
Find your way into CTI Life Sciences Fund L.P.
695 people in our graph share verified history with the CTI Life Sciences Fund L.P. team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Canadian life sciences VC co-created with a major pension fund, acting as a semi-institutional anchor that catalyzes hundreds of millions in follow-on capital despite modest ~$245M fund size.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from public directories
What they invest in
from 19 of 44 portfolio companiesBiotech ×19Healthtech ×8Medical Devices ×7AI & Machine Learning ×4Deep Tech ×3Digital Health ×3Longevity ×2
HQs:United States×5Canada×3Spain×1
Investments · 44 tracked
founders shown can be your intro pathBy year:2026 · 12016 · 12014 · 24 dated
Zymeworks is a biotechnology company that develops novel therapeutics for patients with difficult-to-treat diseases using its proprietary drug-development platforms and in-house R&D.
BiotechHealthtechVancouver, US
ALI TEHRANI(Executive Officer, Director)inGORDON NG(Executive Officer)NEIL KLOMPAS(Executive Officer)inSURJIT DIXIT(Executive Officer)inDAVID TUCKER(Executive Officer)Paul Moore(Chief Scientific Officer)in
Board seatShermaine Tilley· per SEC Form D
Co-investorsBrace PharmaLumira VenturesNextech InvestWUTIF CapitalAmplitude Venture Capital
Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue.
BiotechDeep TechHealthtechMedical DevicesMississauga
Arun Menawat(CEO and Chairman of the Board)inRashed Dewan(Executive Officer)inMathieu Burtnyk(Chief Operating Officer)inTom Tamberrino(Chief Commercial Officer)
BoardJean-Francois Pariseau(Director)Damian Lamb(Director)
Co-investorsFACIT (Fight Against Cancer Innovation Trust)Genesys Capital
BiotechSouth San Francisco, US
Grant E. Pickering(Chief Executive Officer)Ashish Khanna(Executive Officer)Jeff Fairman(Executive Officer)
BoardTracy Saxton(Director)William Newell(Director)Kurt von Emster(Director)in
Co-investorsAbingworthForesite CapitalFrazier Life SciencesJanus Henderson InvestorsLongitude CapitalMedicxi+4 more
Vaxcyte develops broad-spectrum vaccines to prevent bacterial infections, using a cell-free protein synthesis platform and synthetic chemistry techniques.
BiotechHealthtech
Grant Pickering(Founder)inGrant E. Pickering(Chief Executive Officer and Director)in
Co-investorsBioRock VenturesForesite CapitalFrazier Life SciencesLongitude CapitalRA CapitalJanus Henderson Investors+2 more
Thryv Therapeutics is a clinical-stage biotechnology company developing selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1) for inherited cardiac arrhythmias such as Long QT Syndrome and acquired cardiometabolic diseases.
BiotechHealthtechMedical Devices
Paul F. Truex(Chairman of the Board & Chief Executive Officer)inDebra OdinkinAmy Sehnertin
Co-investorsAmzak HealthadMare BioInnovationsAlexandriaLumira Ventures
Oligon Therapeutics develops RNA-based multi-targeting drugs using its SeekR platform, which combines RNA aptamer oligo-binders with siRNA silencers into a single self-delivering molecule for precise targeting of specific cell types, including T-cells and cancer cells.
AI & Machine LearningBiotech
Spyro Mousses(Founder)in
Co-investorsFonds de solidarité FTQ
Thryv Therapeutics is a clinical-stage biotech developing precision-medicine treatments for genetic arrhythmia syndromes and acquired cardiometabolic diseases using selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1).
BiotechDigital HealthMedical Devices
Paul F. Truex(Chairman of the Board & Chief Executive Officer)inDebra Odink(President & Chief Development Officer)inAmy Sehnert(Chief Medical Officer)inMatt Killeen(Chief Business Officer)in
BoardSaumya Das(Chief Scientific Advisor)
Co-investorsLumira VenturesadMare BioInnovationsAmzak HealthFonds de solidarité FTQ
AbilityPharma develops innovative oncology therapies that induce autophagy to treat various cancers and address unmet medical needs.
BiotechDigital HealthHealthtechMedical DevicesGirona, ES
Carles Domenech(Founder)in
Co-investorsCapital CellInveready Technology Investment Group
Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing selective small molecule inhibitors to treat rare genetic and age-related diseases caused by dysregulated cellular metabolism.
BiotechBerkeley, US
Allison J. Hulme(CEO & President)inJohn Kincaid(Chief Scientific Officer)inDavis Ryman(Executive Officer)inMicah Zajic(Executive Officer)inIan Massey(Executive Officer)Stelios Tzannis(Executive Officer, Director)
Co-investorsCoastCapFJ LabsSofinnova VenturesvenBio PartnersApollo Health VenturesvenBio Global Strategic
Apollo is a venture capital firm that invests in life-science and biotechnology startups, combining entrepreneurial expertise with deep scientific knowledge to support early-stage companies in drug development and personalized medicine.
BiotechDeep TechHealthtechLongevity
Nils Regge(Co-Founder & General Partner)in
Co-investorsBLN CapitalCoastCapFJ LabsKfW CapitalTruVenturo GmbHForesite Capital+3 more
Domain Therapeutics is a clinical-stage biopharmaceutical company developing GPCR-targeting therapies to address unmet medical needs in immuno-oncology and inflammation.
BiotechDigital Health
Co-investors3B Future Health FundadMare BioInnovationsPanacea VentureSeventure Partners
enGene is a genetic medicine company developing drug therapies across oncology, urology, and other therapeutic areas, with a focus on patient outcomes.
BiotechMedical Devices
Co-investorsLumira Ventures
Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform.
AI & Machine LearningBiotechHealthtechMontreal, CA
Claude PerreaultPierre Thibault
Co-investorsAdvent Life SciencesCambridge Innovation CapitaladMare BioInnovationsFonds de solidarité FTQ
Find Therapeutics is a clinical-stage biopharmaceutical company developing therapies to treat demyelinating diseases, particularly multiple sclerosis and related conditions affecting myelin repair.
BiotechLongevityMedical DevicesMontreal, CA
Co-investorsadMare BioInnovations
Phenomic AI is a biotech company developing therapies for solid tumors using a machine-learning-powered transcriptomics platform that analyzes single-cell RNA data to identify drug targets and understand tumor biology.
AI & Machine LearningBiotechDeep TechToronto, CA
Sam Cooper(Co-founder & CTO)inOren Kraus(Co-founder)in
Co-investorsCantos VenturesAV8 VenturesGarage CapitalHemi Ventures, LlcToronto Innovation Acceleration PartnersHike Ventures+2 more
A URL shortcut operated by Google that directs users to official Google products and services.
Co-investorsFirst Bight VenturesSwanlaab Venture FactoryAbstract VenturesGeneral CatalystUnion Square Ventures (USV)Y Combinator
.png)
A biologics center of excellence focused on developing and delivering medicines to patients, operating as a subsidiary within the Otsuka pharmaceutical group.
AI & Machine LearningBiotechHealthtechMedical Devices
Zachary Shriver(President and Chief Executive Officer)Karthik Viswanathan(Vice President, Research)in
Co-investorsCycad Group LLCLux CapitalMRL Ventures Fund
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AeovianAmolyt PharmaCellaegisCervelo PharmaceuticalsChlorion PharmaDalCorDalcor PharmacheuticalsEnobiaGlycomineGlypharmaIlkosImvKainovaKainova TherapeuticsMedicagoNeuraxonOligon Rna TherapeuticsPhemiPrecitheraProfoundSomnus TherapeuticsTargegenThryvThryv TherapeuticsVectivBioXageniscXTuit Pharmaceuticals
Exits · 5
4 IPOs · 1 acquisitionsZymeworksNASDAQ: ZYMEProfound MedicalNASDAQ: PROFSutroVaxNASDAQ: PCVXVaxcyteNASDAQ: PCVXVISTERRA, INC.acq. by Otsuka
Portfolio news
latest coverage across their companiesVaxcyte · uk.investing.com · Sep 9, 2026
Profound Medical · stocktitan.net · Sep 3, 2026
social media · theguardian.com · Aug 18, 2026
enGene · marketbeat.com · Aug 15, 2026
Zymeworks · finance.yahoo.com · Jul 1, 2026
Apollo Health Ventures · cen.acs.org · Apr 16, 2026
Aeovian Pharmaceuticals · bioxconomy.com · Dec 18, 2025
Frequently asked questions
- How many investments has CTI Life Sciences Fund L.P. made?
- CTI Life Sciences Fund L.P. has 44 tracked investments, 5 of which have exited, including 1 dated in the last 24 months.
- What stage does CTI Life Sciences Fund L.P. invest at?
- CTI Life Sciences Fund L.P. invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does CTI Life Sciences Fund L.P. focus on?
- CTI Life Sciences Fund L.P. focuses on AI & Machine Learning, Biotech, Healthtech, Medical Devices.
- Where is CTI Life Sciences Fund L.P. located?
- CTI Life Sciences Fund L.P. is headquartered in Montréal, CA.
- Does CTI Life Sciences Fund L.P. lead rounds?
- CTI Life Sciences Fund L.P. typically participates in rounds rather than leading them.
- Who does CTI Life Sciences Fund L.P. co-invest with?
- CTI Life Sciences Fund L.P. most often shares deals with Advent Life Sciences, Lumira Ventures, Sofinnova Partners, among 40 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.